In this study, we evaluated the expression of NG2 on human brain endothelia
l cells derived from temporal lobe tissue resected as a treatment for intra
ctable epilepsy. Using dissociated cell cultures, we found expression of NG
2 on both proliferating and non-proliferating cells, at the mRNA level by r
everse transcription-polymerase chain reaction analyses, and at the protein
level by immunocytochemistry and immunoblotting. We further observed that
human cerebral microvessels in nonmalignant CNS tissues immunoreacted with
NG2. NG2 protein was detected using both a rabbit antibody raised against t
he rodent NG2 and a monoclonal antibody raised against the human NG2 (9.2.2
7). Our findings further define the range of resident cells of the CNS that
can express NG2 and indicate that expression of NG2 by endothelial cells i
s not restricted to proliferating CNS endothelial cells or to endothelial c
ells found in brain tumors.